Eton Pharmaceuticals, Inc. (ETON) Revenue, Earnings & Financial Statements
$63.65NASDAQ: ETONMarket Cap $1.84B
Data as of Nov 17, 2026 close · Statements through the quarter ended Sep 2026 · Source: Financial Modeling Prep (methodology)
Eton Pharmaceuticals, Inc. most recently reported annual revenue of $80.0M, a net loss of $5.0M. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.
Eton Pharmaceuticals, Inc.: net profit was positive in 0 of 9 reported years; operating margin moved from -1939.6% to 0.1%, a shift of +1939.7 percentage points; the most recent year shows a net loss of $5.0M.
Income Statement — 9 Years (USD millions)
Metric
2017
2018
2019
2020
2021
2022
2023
2024
2025
Revenue
$0
$0
$1.0M
$0
$22.0M
$21.0M
$32.0M
$39.0M
$80.0M
Operating Expenses
$7.0M
$10.0M
$20.0M
$27.0M
$23.0M
$30.0M
$33.0M
$42.0M
$80.0M
Operating Profit
−$7.0M
−$10.0M
−$19.0M
−$27.0M
−$1.0M
−$8.0M
−$1.0M
−$3.0M
$0
Operating Margin
—
—
-1939.6%
-69515.4%
-6.8%
-38.9%
-3.8%
-6.7%
0.1%
Other Income
$0
−$2.0M
$0
−$1.0M
$0
−$1.0M
$1.0M
−$1.0M
−$5.0M
Interest
$0
$0
$0
$1.0M
$1.0M
$1.0M
$1.0M
$2.0M
$5.0M
Depreciation
$0
$0
$0
$1.0M
$0
$2.0M
$1.0M
$1.0M
$4.0M
Profit Before Tax
−$7.0M
−$13.0M
−$18.0M
−$28.0M
−$2.0M
−$9.0M
−$1.0M
−$4.0M
−$5.0M
Tax rate (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
-35.9%
-0.4%
-0.9%
Net Profit
−$7.0M
−$13.0M
−$18.0M
−$28.0M
−$2.0M
−$9.0M
−$1.0M
−$4.0M
−$5.0M
EPS
−$0.41
−$1.99
−$1.02
−$1.33
−$0.08
−$0.36
−$0.04
−$0.15
−$0.17
Quarterly Results — Last 12 Quarters (USD millions)
8 duplicate period labels in the source data were collapsed.
Metric
Dec '23
Mar '24
Jun '24
Sep '24
Dec '24
Mar '25
Jun '25
Sep '25
Dec '25
Mar '26
Jun '26
Sep '26
Revenue
$7.0M
$8.0M
$9.0M
$10.0M
$12.0M
$17.0M
$19.0M
$22.0M
$21.0M
$24.0M
$38.0M
$58.0M
Operating Expenses
$9.0M
$9.0M
$12.0M
$10.0M
$11.0M
$18.0M
$20.0M
$24.0M
$19.0M
$22.0M
$25.0M
$35.0M
Operating Profit
−$2.0M
−$1.0M
−$3.0M
$1.0M
$1.0M
$0
−$1.0M
−$1.0M
$2.0M
$2.0M
$13.0M
$23.0M
Operating Margin
-27.3%
-10.0%
-32.4%
4.9%
5.4%
-2.7%
-7.8%
-6.1%
11.6%
9.9%
34.0%
39.7%
Interest
$0
$0
$0
$0
$1.0M
$1.0M
$1.0M
$1.0M
$1.0M
$1.0M
$1.0M
$1.0M
Profit Before Tax
−$2.0M
−$1.0M
−$3.0M
$1.0M
−$1.0M
−$1.0M
−$3.0M
−$2.0M
$1.0M
$2.0M
$12.0M
$22.0M
Tax rate (%)
-12.3%
0.0%
-1.8%
-25.1%
-17.0%
-4.9%
-2.6%
1.4%
-4.9%
1.3%
1.2%
-57.7%
Net Profit
−$2.0M
−$1.0M
−$3.0M
$1.0M
−$1.0M
−$2.0M
−$3.0M
−$2.0M
$1.0M
$2.0M
$12.0M
$35.0M
EPS
−$0.09
−$0.03
−$0.12
$0.02
−$0.02
−$0.06
−$0.10
−$0.07
$0.05
$0.05
$0.35
$1.06
Over the 9 years reported for Eton Pharmaceuticals, Inc., cash stood at $26.0M in the latest year, shareholders' equity was $0, current assets covered current liabilities 1.61 times.
Balance Sheet — 9 Years (USD millions)
Metric
2017
2018
2019
2020
2021
2022
2023
2024
2025
Total Assets
$13.0M
$28.0M
$17.0M
$26.0M
$27.0M
$25.0M
$32.0M
$76.0M
$92.0M
Current Assets
$13.0M
$28.0M
$15.0M
$25.0M
$24.0M
$20.0M
$27.0M
$41.0M
$61.0M
Cash
$13.0M
$27.0M
$12.0M
$21.0M
$14.0M
$16.0M
$21.0M
$15.0M
$26.0M
Inventory
$0
$0
$0
$1.0M
$1.0M
$1.0M
$1.0M
$15.0M
$15.0M
Receivables
$0
$0
$0
$0
$5.0M
$2.0M
$3.0M
$5.0M
$12.0M
Fixed Assets
$0
$1.0M
$1.0M
$1.0M
$0
$0
$0
$0
$1.0M
Capital Work in Progress
$0
$0
$0
$0
$0
$0
$0
$0
$0
Investments
$0
$0
$0
$0
$0
$0
$0
$0
$0
Other Assets
$0
$0
$0
$0
$0
$0
$0
$0
$0
Total Liabilities
$1.0M
$2.0M
$7.0M
$11.0M
$10.0M
$12.0M
$16.0M
$52.0M
$66.0M
Current Liabilities
$1.0M
$2.0M
$2.0M
$4.0M
$5.0M
$6.0M
$16.0M
$20.0M
$38.0M
Borrowings
$0
$0
$5.0M
$7.0M
$7.0M
$7.0M
$5.0M
$30.0M
$31.0M
Other Liabilities
$1.0M
$2.0M
$2.0M
$4.0M
$3.0M
$5.0M
$11.0M
$22.0M
$35.0M
Equity
$0
$0
$0
$0
$0
$0
$0
$0
$0
Reserves
$12.0M
$26.0M
$11.0M
$16.0M
$18.0M
$13.0M
$15.0M
$24.0M
$26.0M
For Eton Pharmaceuticals, Inc., operating cash flow was positive in 4 of 9 reported years; free cash flow in the latest year was $10.0M; free cash flow was positive in 4 of 9 years.
Cash Flow Statement — 9 Years (USD millions)
Metric
2017
2018
2019
2020
2021
2022
2023
2024
2025
Operating Cash Flow
−$5.0M
−$8.0M
−$18.0M
−$22.0M
−$5.0M
$5.0M
$7.0M
$1.0M
$11.0M
Investing Cash Flow
$0
$0
−$4.0M
$0
−$6.0M
−$6.0M
−$2.0M
−$40.0M
−$1.0M
Financing Cash Flow
$18.0M
$0
$0
$0
$0
$0
$0
$0
$0
Net Cash Flow
$13.0M
$14.0M
−$15.0M
$9.0M
−$7.0M
$2.0M
$5.0M
−$6.0M
$11.0M
Free Cash Flow
−$5.0M
−$8.0M
−$20.0M
−$22.0M
−$8.0M
$2.0M
$6.0M
$1.0M
$10.0M
Valuation & Return Ratios
Metric
Value
PEG Ratio
0.00
EV / EBITDA
39.17
FCF Yield
2.16%
Quick Ratio
1.58
Interest Coverage
16.93
Return 1Y
278.73%
Return 3Y
1623.18%
Return 5Y
1262.55%
Eton Pharmaceuticals, Inc. (ETON) financials — frequently asked questions
What is Eton Pharmaceuticals, Inc.'s annual revenue?
Eton Pharmaceuticals, Inc. (ETON) reported annual revenue of $80.0M in its most recent fiscal year.
What is Eton Pharmaceuticals, Inc.'s net profit?
Eton Pharmaceuticals, Inc. (ETON) reported a net loss of $5.0M in its most recent fiscal year.
What is ETON EV/EBITDA?
Eton Pharmaceuticals, Inc.'s enterprise value to EBITDA (EV/EBITDA) ratio is 39.17.
Revenue and earnings of other Drug Manufacturers - Specialty & Generic stocks